The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.
Current price
$369.15Fair Value
$77.98
Upside
Because it considers equity value in its calculation, this formula may not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
| Assets | Price (US$) |
Return 12m |
DY |
P/E |
P/BV |
ROE |
Net Profit Margins |
|---|---|---|---|---|---|---|---|
|
ONC
BeiGene, Ltd.
|
$369.15 | - | 0.00% | 59.26 | 7.51 | 12.67% | 10.70% |
LLY
Eli Lilly and Compay
|
$1,225.73 | 75.80% | 0.54% | 39.62 | 31.24 | 78.84% | 33.53% |
ISRG
Intuitive Surgical Inc.
|
$391.18 | -18.55% | 0.00% | 45.09 | 7.73 | 17.15% | 28.45% |
SNY
Sanofi
|
$44.97 | -6.08% | 4.04% | 7.10 | 1.31 | 18.43% | 13.81% |
NVS
Novartis AG
|
$154.55 | 26.84% | 2.05% | 22.57 | 6.87 | 30.41% | 22.50% |
TMO
Thermo Fisher Scientific Inc.
|
$589.04 | 20.98% | 0.30% | 31.58 | 4.17 | 13.19% | 15.04% |
ABT
Abbott Laboratories
|
$112.68 | -12.19% | 2.33% | 33.60 | 3.57 | 10.61% | 11.65% |
MDT
Medtronic PLC
|
$92.09 | 2.21% | 3.10% | 24.50 | 2.35 | 9.59% | 13.20% |
GSK
GlaxoSmithKline PLC
|
$51.15 | 35.88% | 3.59% | 15.15 | 4.28 | 28.24% | 14.54% |
CVS
CVS Health Corporation
|
$94.91 | 42.72% | 2.73% | 25.48 | 1.56 | 6.12% | 1.18% |
BSX
Boston Scientific Corp.
|
$50.47 | -51.02% | 0.00% | 18.98 | 0.00 | -% | 19.57% |
TMDX
TransMedics Group Inc.
|
$90.69 | -28.90% | 0.00% | 20.36 | 5.96 | 29.28% | 22.69% |
IDXX
IDEXX Laboratories Inc.
|
$553.32 | -14.98% | 0.00% | 38.32 | 27.08 | 70.67% | 25.03% |
RMD
ResMed Inc.
|
$219.98 | -21.78% | 1.07% | 21.40 | 4.95 | 23.13% | 26.94% |
DHR
Danaher Corporation
|
$199.58 | -5.25% | 0.71% | 35.81 | 2.73 | 7.61% | 15.95% |
HCA
HCA Healthcare Inc.
|
$411.73 | 4.71% | 0.74% | 13.12 | -27.97 | -213.15% | 8.77% |
COHR
Coherent Inc.
|
$306.43 | 228.08% | 0.00% | 79.32 | 5.68 | 7.16% | 11.31% |
PHG
Koninklijke Philips NV
|
$27.10 | 2.54% | 3.70% | 20.19 | 1.98 | 9.80% | 6.30% |
SYK
Stryker Corp.
|
$331.37 | -12.12% | 1.02% | 34.97 | 5.44 | 15.55% | 14.43% |
INMD
InMode Ltd.
|
$14.99 | 4.46% | 0.00% | 11.54 | 1.42 | 12.32% | 20.69% |
Average Investor10 user rating
4.0
(0 people)
Founded:
Time since IPO - - year
Employees
BeiGene, Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $38.86 billion, with shareholders equity totaling $5.17 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, BeiGene, Ltd. reported $6.13 billion in revenue, generating net income of $655.71 million.
Key financial metrics include a P/E ratio of 59.26, a price-to-book (P/B) ratio of 7.51, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ONC.
Market cap
$38.86 billion
$38.86 billion
Net worth
$5.17 billion
$5,174,000,000.00
Assets
$9.18 billion
$9,175,610,000.00
Total Shares Outstanding
112.00 million
112,000,000
Average Daily Trading Volume
$368.59 Thousand
$368,590.72
Sector
Health
Industry
Pharmaceutical Products
Shares
25.48
2.73%
6.12%
1.56
10.82
2.19%
16.04%
1.74
-6.48
0.00%
-22.51%
1.46
36.20
0.92%
6.63%
2.40
7.10
4.04%
18.43%
1.31
39.62
0.54%
78.84%
31.24
13.12
0.74%
-213.15%
-27.97
22.57
2.05%
30.41%
6.87
25.48
2.73%
6.12%
1.56
10.82
2.19%
16.04%
1.74
-6.48
0.00%
-22.51%
1.46
36.20
0.92%
6.63%
2.40
7.10
4.04%
18.43%
1.31
39.62
0.54%
78.84%
31.24
13.12
0.74%
-213.15%
-27.97
22.57
2.05%
30.41%
6.87
A cotação de BeiGene, Ltd. (ONC) hoje está em US$ 369.15, com uma variação de 0% em relação ao último ano. A cotação de BeiGene, Ltd. (ONC) iniciou o ano negociando na casa dos US$ 303.81 e hoje está em US$ 369.15. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de BeiGene, Ltd. (ONC) e dados de ações do Ibovespa e mercados internacionais.
BeiGene, Ltd. (ONC) não distribuiu dividendos no último ano.
Atualmente, BeiGene, Ltd. (ONC) está cotada a US$ 369.15, com um P/L de 59.26, representando um desvio de 3,543% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.
Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.
Investir em ações de BeiGene, Ltd. (ONC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.
A rentabilidade de BeiGene, Ltd. (ONC) foi de 18.32% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).
Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.
Se você quisesse comprar 100 ações de BeiGene, Ltd. (ONC) hoje, o investimento total seria de US$ 36,915.00, com base na cotação atual de US$ 369.15.
Based on historical performance, the investment would have grown to approximately:
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Stock Rankings
ETF Rankings
Crypto Rankings
See Graham's ranking